Effect of antibiotic treatment on Mycoplasma hyopneumoniae detection and infectious potential.


Journal

Veterinary microbiology
ISSN: 1873-2542
Titre abrégé: Vet Microbiol
Pays: Netherlands
ID NLM: 7705469

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 11 05 2021
accepted: 29 08 2021
pubmed: 21 9 2021
medline: 17 12 2021
entrez: 20 9 2021
Statut: ppublish

Résumé

Mycoplasma hyopneumoniae (M. hyopneumoniae) causes significant economic losses in the swine industry. Antibiotics with activity against Mycoplasma spp. are employed for disease mitigation and pathogen elimination. However, veterinarians are often challenged with the detection of M. hyopneumoniae by PCR after antibiotic treatment, thus raising the question whether the bacterium is still infectious. The objective of this study was to evaluate the effect of tulathromycin treatment on M. hyopneumoniae detection and infectious potential during the acute and chronic phases of infection. For each infection phase, one age-matched naïve gilt was placed in contact with one M. hyopneumoniae infected gilt that was either treated with tulathromycin, treated and vaccinated, or non-treated, for 14 days. Four replicates per treatment group were performed for each infection phase. A numerical reduction in relative bacterial load was observed in acutely treated gilts compared to non-treated gilts. The rate at which naïve gilts became infected with M. hyopneumoniae was numerically reduced when co-housed with treated, acutely infected gilts compared to those housed with non-treated, infected gilts. During the chronic infection phase, M. hyopneumoniae was detected by PCR in more than 50 % of treated infected gilts and persisted for up to three months post-treatment. Transmission was not detected in all treatment groups however, the possibility that the pathogen was infectious could not be completely ruled out. Further research focused on assessing M. hyopneumoniae detection and viability post-treatment is necessary to guide control and elimination efforts.

Identifiants

pubmed: 34544009
pii: S0378-1135(21)00245-5
doi: 10.1016/j.vetmic.2021.109222
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Disaccharides 0
Heterocyclic Compounds 0
tulathromycin Q839I13422

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109222

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Alyssa M Betlach (AM)

Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA; Swine Vet Center, St. Peter, MN, USA.

David Baumert (D)

Zoetis, Parsippany, NJ, USA.

Vitelio Utrera (V)

Zoetis, Parsippany, NJ, USA.

Lucina Galina Pantoja (L)

Zoetis, Parsippany, NJ, USA.

Maria Pieters (M)

Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA; Veterinary Diagnostic Laboratory, University of Minnesota, St. Paul, MN, USA. Electronic address: piet0094@umn.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH